Publiserte artikler 2019
El-Salhy M, Hatlebakk JG, Gilja OH, Bråthen Kristoffersen A, Hausken T Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut 2019 Dec 18. Epub 2019 des 18.
El-Salhy M, Hatlebakk JG, Hausken T Possible role of peptide YY (PYY) in the pathophysiology of irritable bowel syndrome (IBS). Neuropeptides 2019 Oct 24. Epub 2019 okt 24.
Dale HF, Jensen C, Hausken T, Lied E, Hatlebakk JG, Brønstad I, Hoff DAL, Lied GA Acute effect of a cod protein hydrolysate on postprandial acylated ghrelin concentration and sensations associated with appetite in healthy subjects: a double-blind crossover trial. Food Nutr Res 2019;63(). Epub 2019 okt 22.
El-Salhy M, Hatlebakk JG, Hausken T Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones. Nutrients 2019 Aug 07;11(8). Epub 2019 aug 7.
Pauwels A, Boecxstaens V, Andrews CN, Attwood SE, Berrisford R, Bisschops R, Boeckxstaens GE, Bor S, Bredenoord AJ, Cicala M, Corsetti M, Fornari F, Gyawali CP, Hatlebakk J, Johnson SB, Lerut T, Lundell L, Mattioli S, Miwa H, Nafteux P, Omari T, Pandolfino J, Penagini R, Rice TW, Roelandt P, Rommel N, Savarino V, Sifrim D, Suzuki H, Tutuian R, Vanuytsel T, Vela MF, Watson DI, Zerbib F, Tack J How to select patients for antireflux surgery? The ICARUS guidelines (international consensus regarding preoperative examinations and clinical characteristics assessment to select adult patients for antireflux surgery). Gut 2019 11;68(11):1928-1941. Epub 2019 aug 2.
El-Salhy M, Hausken T, Hatlebakk JG Increasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS). Nutrients 2019 Jun 24;11(6). Epub 2019 jun 24.
Mazzawi T, Hausken T, Hov JR, Valeur J, Sangnes DA, El-Salhy M, Gilja OH, Hatlebakk JG, Lied GA Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels. Scand J Gastroenterol 2019 Jun;54(6):690-699. Epub 2019 jun 13.
El-Salhy M, Gilja OH, Hatlebakk JG Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting. Mol Med Rep 2019 Jul;20(1):787-794. Epub 2019 mai 23.
Pham H, Holen IS, Phillips LK, Hatzinikolas S, Huynh LQ, Wu T, Hausken T, Rayner CK, Horowitz M, Jones KL The Effects of a Whey Protein and Guar Gum-Containing Preload on Gastric Emptying, Glycaemia, Small Intestinal Absorption and Blood Pressure in Healthy Older Subjects. Nutrients 2019 Nov 05;11(11). Epub 2019 nov 5.
Dale HF, Rasmussen SH, Asiller ÖÖ, Lied GA Probiotics in Irritable Bowel Syndrome: An Up-to-Date Systematic Review. Nutrients 2019 Sep 02;11(9). Epub 2019 sep 2.
Dale HF, Jensen C, Hausken T, Valeur J, Hoff DAL, Lied GA Effects of a Cod Protein Hydrolysate Supplement on Symptoms, Gut Integrity Markers and Fecal Fermentation in Patients with Irritable Bowel Syndrome. Nutrients 2019 Jul 17;11(7). Epub 2019 jul 17.
El-Salhy M Nutritional Management of Gastrointestinal Diseases and Disorders. Nutrients 2019 Dec 10;11(12). Epub 2019 des 10.
Dale HF, Madsen L, Lied GA Fish-derived proteins and their potential to improve human health. Nutr Rev 2019 May 24. Epub 2019 mai 24.
Jensen C, Dale HF, Hausken T, Lied E, Hatlebakk JG, Brønstad I, Lied GA, Hoff DAL. Supplementation with cod protein hydrolysate in older adults: a dose range cross-over study. Journal of Nutritional Science. 2019;8:e40.
Transeth EL, Dale HF, Lied GA. Comparison of gut microbiota profile in celiac disease, non-celiac gluten sensitivity and irritable bowel syndrome: A systematic review. Turkish Journal of Gastroenterology. 2019.